Panel Partly Reverses, Says Diabetes Treatment Is Patent-Eligible

Mealey's (March 18, 2020, 11:11 AM EDT) -- WASHINGTON, D.C. — Although reversing and remanding a New Jersey federal judge’s determination that various claims of one patent covering a type of treating type 2 diabetes mellitus is drawn to...
To view the full article, register now.